trending Market Intelligence /marketintelligence/en/news-insights/trending/b89ORDxFhwSLkh9OE5E3BA2 content esgSubNav
In This List

Orchard Therapeutics completes $110M financing, appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Orchard Therapeutics completes $110M financing, appoints director

Orchard Therapeutics Ltd completed an oversubscribed $110 million series B financing.

The company said Baillie Gifford and ORI Capital co-led the financing.

In connection with the financing, Simone Song, senior partner at ORI Capital, was appointed to Orchard's board of directors.

Orchard said it plans to use the proceeds to move its pipeline forward, including the launch of its gene therapy OTL-101.